Should I buy Reckitt Benckiser shares in the United Kingdom in 2025?

Why trust HelloSafe ?

At HelloSafe, our specialist has been tracking the Reckitt Benckiser share price for over three years. Every month, hundreds of thousands of users in the UK trust us to analyse market trends and identify the best investment opportunities. Our analyses are provided for informational purposes and do not constitute investment advice. In accordance with our ethical charter, we have never been, and will never be, compensated by Reckitt Benckiser.

What is Reckitt Benckiser?

What is the price of Reckitt Benckiser stock?

The price of Reckitt Benckiser stock is rising this week.

Currently, Reckitt Benckiser trades at 5,062 GBX, with a 24-hour change of -0.32% and a weekly gain of +2.41%. The company’s market capitalisation stands at £34.49 billion, with an average daily volume of 1.62 million shares (3-month average). The stock shows a P/E Ratio of 24.81, offers a dividend yield of 4.08%, and maintains a low beta of 0.10. This low volatility, coupled with steady growth, makes Reckitt Benckiser an appealing choice for investors seeking stability.

Our full analysis of the Reckitt Benckiser stock

After reviewing Reckitt Benckiser’s latest financial results alongside its stock performance over the past three years, our multi-factor analysis—merging financial indicators, technical signals, market intelligence, and peer benchmarking—leverages proprietary algorithms to deliver unique insight. This enables us to assess the company’s position within the fast-evolving consumer health and hygiene sector. So, why might Reckitt Benckiser stock once again become a strategic entry point into the consumer staples sector in 2025?

Recent performance and market context

Reckitt Benckiser has shown impressive resilience in 2025, with its stock price at 5,062 GBX as of 4 July, marking a weekly rise of +2.41% and +3.96% over the last six months. Over the previous year, the stock delivered a significant +18.91% gain, notably outperforming many defensive peers. Positive momentum has been driven by robust performance in emerging markets (+10.7% organic growth), continued product innovation, and disciplined execution in its strategic separation and cost control programmes. Against the broader sector backdrop, the consumer staples category has benefited from persistent demand for hygiene and health products, strong brand loyalty, and a defensive tilt amid macroeconomic uncertainty.

Technical analysis

On the technical front, Reckitt Benckiser is in a structurally bullish setup. The stock trades above all long-term moving averages (20, 50, 100, and 200 days), confirming persistent upward momentum. The 14-day RSI is at a neutral 54–56, suggesting the advance is not overheated. MACD momentum is positive (+3.78), reinforcing bullish sentiment, while the consensus from multiple technical signals (“Strong Buy” on TradingView) supports the constructive view. Key support lies in the 4,855–4,930 GBX range, while resistance is clustered between 5,125–5,296 GBX. This strong technical foundation, with higher lows and a clear uptrend, suggests continued outperformance is likely, especially as the stock trades near—but not above—major resistance, offering tactical entry points.

Fundamental analysis

Reckitt Benckiser’s fundamentals paint a picture of stability and steady growth. Q1 2025 revenue reached £3.68 billion (+1.1% organic growth), in line with market expectations. Segment performance remains robust: “Core Reckitt” grew 3.1% organically, while emerging market strength continues to offset modest declines in mature regions. Profitability is underpinned by a healthy dividend yield of 4.08% and a strong earnings base (P/E ratio 24.81), reflecting sector-leading cash generation. The in-progress separation of Essential Home will allow focus on higher-margin “Powerbrands,” while operational efficiency gains from the “Fuel for Growth” programme—targeting a reduction of fixed costs from 22% to 19% by 2027—should support margin expansion. The company’s brand power in segments like Germ Protection (Dettol, Lysol) and Intimate Wellness (Durex) continues to anchor recurring revenues and market share.

Strategically, Reckitt Benckiser’s £145.5m investment in new manufacturing capacity and disciplined M&A activity strengthen its footprint and future-proof its supply chain. Overall, the stock’s valuation remains attractive in a sector valued for predictability and reliability.

Volume and liquidity

Trading volume in Reckitt Benckiser remains strong, with a 3-month average daily turnover of 1.62 million shares. This sustained liquidity demonstrates ongoing investor interest and instils confidence in price discovery and fair value, supporting both institutional and retail participation. The substantial free float (nearly half of the company’s 679 million shares in issue) creates fertile ground for dynamic valuation and efficient capital flows—essential for responsive pricing, especially as new catalysts approach.

Catalysts and positive outlook

• Product Innovation: Recent launches—such as Durex Nitrile and Lysol Laundry Sanitizer—are expanding leadership in high-margin, high-growth categories.
• Strategic Restructuring: The scheduled separation and sale of Essential Home signals a laser focus on core, high-performing brands. The “Fuel for Growth” programme underpins cost discipline and operational agility.
• Geographic Expansion: Continued outperformance in China and India provides a robust platform as emerging markets deliver double-digit growth.
• Shareholder Value Initiatives: £815m of buybacks executed since 2024, part of a £1bn programme, reinforce management’s confidence and return capital to investors.
• Sustainability and ESG: Ongoing environmental initiatives and responsible sourcing practices are appealing to ESG-focused investors and position Reckitt Benckiser favourably with regulatory shifts and consumer expectations.
• Sector Tailwinds: The consumer staples sector’s resilience amid global uncertainty, along with innovation in health and hygiene, strengthens Reckitt Benckiser’s competitive edge.

With major interim results due on 24 July 2025, further positive surprises could serve as triggers for another valuation re-rating.

Investment strategies

• Short-Term: With the stock trading near all-time highs and strong support levels established, tactical investors may consider accumulating positions ahead of key catalysts—particularly the 24 July results and the anticipated Essential Home transaction.
• Medium-Term: Operational restructuring, product innovation, and strategic buybacks provide a framework for above-market returns as margin expansion and growth initiatives gain traction in late 2025 and 2026.
• Long-Term: Reckitt Benckiser’s commitment to its “Powerbrands,” disciplined capital allocation, leading positions in essential consumer categories, and robust dividend policy form a solid foundation for long-term value creation, ideal for defensive portfolios seeking reliable, inflation-resilient total returns.

Positioning at the current price band—in proximity to a breakout above 5,125 GBX resistance or on pullbacks towards the 4,900 GBX support zone—appears tactically optimal for building exposure before the next wave of catalysts is realised.

Is it the right time to buy Reckitt Benckiser?

Reckitt Benckiser’s combination of steady growth, resilient sector positioning, and operational momentum justifies renewed investor attention at this juncture. The stock’s compelling technical profile, consistently robust fundamentals, elevated liquidity, and clear catalysts foster a favourable risk/reward balance. As Reckitt Benckiser successfully executes on its strategic priorities—streamlining the portfolio, driving innovation, and returning value to shareholders—it may well be entering a new bullish phase.

With solid support underpinning the current price and several significant growth levers set to be activated in the coming quarters, Reckitt Benckiser seems to represent an excellent opportunity for investors seeking exposure to a leading name in the global consumer staples sector with a proven capacity for resilience and long-term performance.

How to buy Reckitt Benckiser stock in the UK?

Buying Reckitt Benckiser stock online is both straightforward and secure when you use a regulated UK broker. Investors can choose between two main approaches: buying shares outright (spot buying) to become a direct shareholder, or trading via Contracts for Difference (CFDs) for more flexibility and leverage. Both methods have their advantages depending on your strategy and risk profile. To help you decide, we provide a comprehensive broker comparison further down the page.

Spot buying

A cash purchase of Reckitt Benckiser stock means you directly own the shares, benefiting from any dividends and capital appreciation. Most UK brokers charge a fixed commission per order—typically around £5 to £10. This is ideal for those seeking long-term growth and potential dividend income through company ownership.

Gain scenario

If the Reckitt Benckiser share price is £50.62, you can buy around 19 shares with a £1,000 stake, including a brokerage fee of around £5.

If the share price rises by 10%, your shares are now worth £1,100.

Result: +£100 gross gain, i.e. +10% on your investment.

Trading via CFD

CFD trading lets you speculate on Reckitt Benckiser's share price movements without directly owning the shares. With CFDs, you can use leverage—often up to 5:1—so a small amount of capital controls a larger market exposure. Fees typically include the spread (difference between buy and sell prices) and overnight financing costs if you keep positions open for more than a day.

CFD Gain Scenario: Reckitt Benckiser

You open a CFD position on Reckitt Benckiser shares, with 5x leverage and a £1,000 stake.

This gives you a market exposure of £5,000.

Gain scenario:

If the stock rises by 8%, your position gains 8% × 5 = 40%.

Result: +£400 gain, on a bet of £1,000 (excluding fees).

Final advice

Before investing, it's crucial to compare brokers' fees, commissions, and the trading tools they offer, as these can significantly impact your returns. Ultimately, the best approach—spot buying or CFD trading—will depend on your personal goals, risk tolerance, and investment timeframe. For a detailed broker comparison and expert tips, see the section further down this page.

Our 7 tips for buying Reckitt Benckiser stock

The latest news about Reckitt Benckiser

Reckitt Benckiser’s share price has gained over 2.4% on the London Stock Exchange this week. Following a period of structural consolidation, the stock has outperformed several FTSE 100 peers, with trading volumes averaging 1.62 million shares per day, reflecting growing investor appetite in the UK market and supporting a sustained upward trend confirmed by technical signals.

The upcoming H1 2025 results, scheduled for 24 July, are drawing heightened analyst attention in Britain. The local market is anticipating confirmation of resilient revenue growth—driven by continued demand for hygiene products and ongoing developments in emerging markets—which could provide fresh upside for the stock as investors position ahead of the release.

Reckitt Benckiser has already completed £815 million of its £1 billion share buyback programme targeting LSE-listed shares. This substantial capital return initiative supports the share price, enhances earnings per share for UK-based holders, and is seen as a sign of management’s confidence in long-term shareholder value creation.

The group’s “Fuel for Growth” strategy is progressing, with specific UK relevance as the headquarters remain in Slough. By streamlining operations and targeting a reduction in fixed costs to 19% by 2027, Reckitt Benckiser strengthens its competitive edge in the British market, ensuring profitability and creating potential for margin expansion amid changing sector dynamics.

Technical analyst consensus for Reckitt Benckiser currently stands at “Strong Buy” on the LSE, underpinned by bullish momentum. With the stock trading above most long-term moving averages and the MACD flashing a buy signal, UK institutional and retail investors continue to display confidence in sustained performance, especially as future product innovations and strategic initiatives are rolled out from the company’s British base.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.